Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.

Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M; International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3).

J Infect Dis. 2012 May 1;205(9):1342-50. doi: 10.1093/infdis/jis213. Epub 2012 Mar 29. Erratum in: J Infect Dis. 2012 Aug 15;206(4):624. InC Collaborative Group [corrected to International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3)].

2.

Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.

Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP.

Clin Infect Dis. 2013 Feb;56(3):405-13. doi: 10.1093/cid/cis921. Epub 2012 Oct 22.

3.

Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.

Sacks-Davis R, McBryde E, Grebely J, Hellard M, Vickerman P.

J R Soc Interface. 2015 Mar 6;12(104):20141197. doi: 10.1098/rsif.2014.1197.

4.

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hellard M.

Hepatology. 2008 Dec;48(6):1746-52. doi: 10.1002/hep.22534.

PMID:
18844233
5.

Hepatitis C virus reinfection in injection drug users.

Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW.

Hepatology. 2006 Nov;44(5):1139-45.

PMID:
17058216
6.

High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.

Sacks-Davis R, Aitken CK, Higgs P, Spelman T, Pedrana AE, Bowden S, Bharadwaj M, Nivarthi UK, Suppiah V, George J, Grebely J, Drummer HE, Hellard M.

PLoS One. 2013 Nov 7;8(11):e80216. doi: 10.1371/journal.pone.0080216. eCollection 2013.

7.

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ; International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3).

Lancet Infect Dis. 2012 May;12(5):408-14. doi: 10.1016/S1473-3099(12)70010-5. Review.

8.

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs.

Weir A, McLeod A, Innes H, Valerio H, Aspinall EJ, Goldberg DJ, Barclay ST, Dillon JF, Fox R, Fraser A, Hayes PC, Kennedy N, Mills PR, Stanley AJ, Aitken C, Gunson R, Templeton K, Hunt A, McIntyre P, Hutchinson SJ.

Drug Alcohol Depend. 2016 Aug 1;165:53-60. doi: 10.1016/j.drugalcdep.2016.05.012. Epub 2016 May 28.

PMID:
27268294
9.

Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.

Pineda JA, Núñez-Torres R, Téllez F, Mancebo M, García F, Merchante N, Pérez-Pérez M, Neukam K, Macías J, Real LM; HEPAVIR Group of The Andalusian Society of Infectious Diseases (SAEI).

J Infect. 2015 Nov;71(5):571-7. doi: 10.1016/j.jinf.2015.07.006. Epub 2015 Jul 23.

PMID:
26212868
10.

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

van de Laar TJ, Molenkamp R, van den Berg C, Schinkel J, Beld MG, Prins M, Coutinho RA, Bruisten SM.

J Hepatol. 2009 Oct;51(4):667-74. doi: 10.1016/j.jhep.2009.05.027. Epub 2009 Jun 18.

PMID:
19646773
11.

Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study.

Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M; InC3 study group.

J Infect Dis. 2015 Nov 1;212(9):1407-19. doi: 10.1093/infdis/jiv220. Epub 2015 Apr 15.

12.

Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.

Grady BP, Vanhommerig JW, Schinkel J, Weegink CJ, Bruisten SM, Lindenburg CE, Prins M.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1302-7.

PMID:
22825643
13.

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Micallef JM, Macdonald V, Jauncey M, Amin J, Rawlinson W, van Beek I, Kaldor JM, White PA, Dore GJ.

J Viral Hepat. 2007 Jun;14(6):413-8.

PMID:
17501762
14.

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.

Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, Lloyd AR, White PA.

Hepatology. 2010 Nov;52(5):1564-72. doi: 10.1002/hep.23885.

PMID:
21038409
15.

Reinfection with hepatitis C virus following sustained virological response in injection drug users.

Grebely J, Knight E, Ngai T, Genoway KA, Raffa JD, Storms M, Gallagher L, Krajden M, Dore GJ, Duncan F, Conway B.

J Gastroenterol Hepatol. 2010 Jul;25(7):1281-4. doi: 10.1111/j.1440-1746.2010.06238.x.

PMID:
20594256
16.

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Page K, Hahn JA, Evans J, Shiboski S, Lum P, Delwart E, Tobler L, Andrews W, Avanesyan L, Cooper S, Busch MP.

J Infect Dis. 2009 Oct 15;200(8):1216-26. doi: 10.1086/605947.

17.

A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.

Currie SL, Ryan JC, Tracy D, Wright TL, George S, McQuaid R, Kim M, Shen H, Monto A.

Drug Alcohol Depend. 2008 Jan 11;93(1-2):148-54. Epub 2007 Oct 30. Erratum in: Drug Alcohol Depend. 2008 Jul;96(1-2):192.

PMID:
17977668
18.

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.

Aitken CK, Agius PA, Higgs PG, Stoové MA, Bowden DS, Dietze PM.

Epidemiol Infect. 2017 Mar;145(4):796-801. doi: 10.1017/S0950268816002892. Epub 2016 Dec 8.

PMID:
27927256
19.

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.

van den Berg CH, Grady BP, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, Coutinho RA, van Baarle D, Prins M.

PLoS One. 2011;6(11):e27555. doi: 10.1371/journal.pone.0027555. Epub 2011 Nov 15.

20.

Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.

McDonald SA, Hutchinson SJ, Cameron SO, Innes HA, McLeod A, Goldberg DJ.

Int J Drug Policy. 2012 Sep;23(5):353-7. doi: 10.1016/j.drugpo.2012.02.003. Epub 2012 Mar 14.

PMID:
22421553

Supplemental Content

Support Center